LipiRADICAL Green (Lipid Radical Detection Reagent)

Product#: FNK-FDV-0042
$454.48
Availability:
Ships in 24 hours

Funakoshi · Cell Imaging Probes

LipiRADICAL Green (Lipid Radical Detection Reagent)

A fluorescent probe that selectively detects lipid radicals, the primary products of lipid peroxidation (LPO); reaction with a lipid radical restores green fluorescence (Ex 470 nm / Em ~540 nm).
For Research Use Only.

Funakoshi Co., Ltd. · Distributed by Diagnocine
Cat No.
FNK-FDV-0042
UNSPSC Code
12352206
Size
0.1 mg
Storage
-20°C, protect from light

Filter compatibility: Conventional FITC filter sets are compatible.

Overview

LipiRADICAL Green is a lipid radical-responsive fluorescent dye: an NBD-conjugated nitroxyl radical derivative. It selectively detects lipid radicals, not reactive oxygen radicals. LipiRADICAL Green enables semi-quantification of lipid radicals in biological samples, imaging of cellular lipid radicals, and identification and structural analysis of lipid radicals with an LC/MS system.

POINT

LipiRADICAL Green is the world’s first lipid radical-responsive fluorescent dye. Unlike general oxidative stress markers, it forms a covalent bond with the lipid radical, so the exact molecular species of the radical can be identified by LC-FL/MS-MS.

Background: Lipid Peroxidation

Lipid peroxidation (LPO) is one of several degradation processes of lipids under oxidative stress. The primary products of LPO are lipid radicals. Two major initiators induce LPO: pro-oxidants, and lipid oxidative enzymes including lipoxygenase (LOX) and cytochrome P450 (CYP).

Lipid peroxidation pathway under oxidative stress
LPO process (1): Pro-oxidants

Lipids containing unsaturated fatty acids, especially polyunsaturated fatty acids (PUFAs), are attacked by pro-oxidants, including reactive oxygen species (ROS), and form lipid-derived radicals. The lipid radical (L•) is easily oxidized to the lipid peroxyl radical (LOO•). Unstable LOO• immediately extracts a hydrogen from another lipid molecule, generating a lipid hydroperoxide (LOOH) and a new lipid radical (L•).

LPO process (2): Lipid oxidative enzymes

In enzyme-induced LPO, lipids containing PUFAs are oxidized to lipid hydroperoxides (LOOH), which decompose to lipid peroxyl radicals (LOO•) or alkoxyl radicals (LO•) in the presence of metal ions (Fe2+, etc.).

Propagation
Lipid radicals produced by either process expand the radical chain reaction
Termination
Antioxidants donate a hydrogen atom to LOO•, forming aldehydes: MDA, acrolein, propanal, hexanal and 4-HNE
Toxicity
Reactive aldehydes attack proteins and DNA/RNA, forming secondary products

These reactive aldehydes are cytotoxic and are considered causative factors of organ injury, ferroptosis and ER stress. Understanding the molecular mechanism and physiological relevance of LPO requires methods to detect and quantify lipid radicals, but conventional methods are highly limited. For example, electron spin resonance (ESR) is a major strategy to detect radical products but is not applied to cell-based assays.

Overview of lipid radicals in the LPO pathway
Overview of lipid radicals in the LPO pathway.

Detection Principle

Step 1 · Quenched
The NBD fluorescence is highly quenched by the intramolecular nitroxyl radical moiety
Step 2 · Coupling
The probe reacts with a lipid radical by radical-radical coupling and binds the lipid covalently
Step 3 · Signal
Fluorescence intensity is drastically recovered (green, Ex 470 nm / Em ~540 nm)
Principle of LipiRADICAL Green lipid radical detection
Principle of LipiRADICAL Green.

Applications

In vitro detection

In vitro detection of lipid radicals by fluorescence.

Live-cell imaging

Live-cell imaging of lipid radicals by fluorescence microscopy.

Antioxidant screening

Screening of LPO suppressors or antioxidants, in vitro or in cellulo.

Structural analysis

Structural analysis of lipid radicals by fluorescence LC/MS-MS.

Specifications

LipiRADICAL Green
Cat No. FNK-FDV-0042
Size 0.1 mg
Molecular formula C19H28N5O4
Molecular weight 390.21 g/mol
Solubility Soluble in DMSO
Ex / Em 470 nm / 520-600 nm (maximum ~540 nm)
Filter set Conventional FITC filter sets are compatible

Chemical Structure

LipiRADICAL Green chemical structure

Reconstitution & Storage

Reconstitution
Recommended stock solution: 1 mM in 100% DMSO.
Powder
Store at -20°C.
Stock solution
Aliquot and store at -20°C. Protect from light.
Handling
Avoid repeated freeze-thaw cycles.

Application Data

Cell-Based Detection of Lipid Radicals Induced by Diethylnitrosamine (DEN)

Hepa1-6 cells were treated with 1 µM LipiRADICAL Green for 20 min and washed twice with PBS. To induce an LPO signal, the cells were co-treated with LipiRADICAL Green and diethylnitrosamine (DEN), an LPO initiator. Immediately after DEN addition, the cells were observed by confocal microscopy (Ex 458 nm / Em 490-674 nm) for 20 min at 2-min intervals. The LipiRADICAL Green signal from DEN-treated cells clearly increased.

LipiRADICAL Green live-cell imaging of DEN-induced lipid radicals in Hepa1-6 cells

In Vitro Detection of Lipid Radicals Derived from LDL

Purified low-density lipoprotein (LDL, 20 µg protein/mL) was mixed with the pro-oxidant hemin or AAPH and LipiRADICAL Green, and green fluorescence (Ex 470 nm / Em 530 nm) was measured for 60 min at 37°C. Both hemin and AAPH increased green fluorescence in a time-dependent manner, indicating the production of lipid radicals from LDL particles.

Time course of LipiRADICAL Green fluorescence with LDL and hemin or AAPH

Structural Analysis of Lipid Radicals Derived from Arachidonic Acid In Vitro

Arachidonic acid (AA; 500 µM) was incubated with a mixture of the pro-oxidants hemin (10 µM) and AAPH (50 mM) for 60 min. After incubation, 5 µM LipiRADICAL Green was added to the reaction mixture and incubated for 15 min at room temperature. Lipid components were extracted by the Bligh and Dyer method and analyzed by LC-FL/MS-MS.

  • Upper panel: Fluorescence chromatogram (Ex 470 nm / Em 530 nm). Each fluorescent peak was further analyzed by MS-MS.
  • Lower panel: Product profiles of AA-derived radicals. MS-MS identified 8 full-length AA radicals and 29 truncated radicals. Relative abundances were calculated from each peak area.
The detailed experimental protocol and analytical procedure are described in Ref. 5.
LC-FL/MS-MS chromatogram and profile of arachidonic acid-derived lipid radicals

Structural Analysis of Lipid Radicals In Vivo

Diethylnitrosamine (DEN, 100 mg/kg body weight), a well-known carcinogen, was injected intraperitoneally into mice; after 1, 4 and 24 hours the mice were anesthetized and received intraperitoneal LipiRADICAL Green (2.5 µmol/kg body weight). To check specificity, OH-Pen, a specific inhibitor of lipid radicals (10 µmol/kg body weight), was injected before LipiRADICAL Green. Livers were removed and homogenized in methanol, lipids were extracted by the Bligh and Dyer method, and the lipid samples were analyzed by LC-FL/MS-MS.

  • Left: Lipid radical production was high 4 hours after DEN treatment; 11 lipid radicals were identified.
  • Right: Example: the •C5H11 radical. OH-Pen pre-injection clearly inhibited DEN-induced lipid radical production.
LC-FL/MS-MS of liver lipid radicals after DEN injection with and without OH-Pen

Reference Data: Spectrum & Specificity

Fluorescence Spectrum

LipiRADICAL Green was added to arachidonic acid-lipoxygenase (LOX) mixtures, and fluorescence was observed with 470 nm excitation. Without LOX, the signal was highly quenched (black line). With LOX, green fluorescence (500-650 nm, maximum ~540 nm) was detected in a LOX dose-dependent manner.

LipiRADICAL Green fluorescence spectra with increasing lipoxygenase

Specificity

LipiRADICAL Green was treated with the reagents below, and fluorescence intensity (Ex 470 nm / Em 530 nm) was measured. Reactive oxygen species had little effect on the fluorescence. Green fluorescence was observed only with polyunsaturated lipids (linoleic acid (LA), α-linolenic acid (ALA) or arachidonic acid (AA)) in combination with LOX or the pro-oxidants AAPH and MeO-AMVN.

Reagent Concentration
LipiRADICAL Green 5 µM
H2O2, ClO-, KO2 (for O2•-), •OH 0.5 mM
Lipids (LA, ALA, AA) 0.5 mM
LOX 2.5 µg/mL
AAPH 10 mM
MeO-AMVN 50 µM
LipiRADICAL Green specificity for lipid radicals versus reactive oxygen species

Research Applications

Publications from the References section, grouped by application area.

LipiRADICAL Green lipid radical detection reagent FNK-FDV-0042 research applications
Visualization & Live-Cell Imaging

Spatial and temporal production of lipid radicals in live cells.

Structural Analysis (LC-FL/MS-MS)

Identification of the molecular species of lipid radicals through the stable covalent adduct.

In Vivo & Tissue-Level Detection

Lipid radical production in animal models of disease.

Antioxidant & Suppressor Screening

Evaluation of drugs and cellular defense mechanisms against LPO.

  • Antiferroptotic agents: Mishima et al. (2020), repurposed drugs acting as lipid peroxyl radical scavengers suppress AKI.
  • Metabolic defense: Shinjyo et al. (2025), aldehyde metabolism and mucociliary clearance after air pollution exposure.

References

Research use only; not for diagnostic or therapeutic use.

  1. Yamada K. et al., (2016). Fluorescence probes to detect lipid-derived radicals. Nat. Chem. Biol. 12(8):608-613. 10.1038/nchembio.2105
  2. Enoki M. et al., (2017). Lipid radicals cause light-induced retinal degeneration. Chem. Commun. 53(79):10922-10925. 10.1039/c7cc03387g
  3. Ishida Y. et al., (2017). Detection and inhibition of lipid-derived radicals in low-density lipoprotein. Free Radic. Biol. Med. 113:487-493. 10.1016/j.freeradbiomed.2017.10.388
  4. Mishima E. et al., (2020). Drugs repurposed as antiferroptosis agents suppress organ damage, including AKI, by functioning as lipid peroxyl radical scavengers. J. Am. Soc. Nephrol. 31(2):280-296. 10.1681/ASN.2019060570
  5. Matsuoka Y. et al., (2020). Method for structural determination of lipid-derived radicals. Anal. Chem. 92(10):6993-7002. 10.1021/acs.analchem.0c00053
  6. Mishima E. et al., (2022). A non-canonical vitamin K cycle is a potent ferroptosis suppressor. Nature 608(7924):778-783. 10.1038/s41586-022-05022-3
  7. Mathew M. et al., (2024). Induction of oxidative stress and ferroptosis in triple-negative breast cancer cells by niclosamide via blockade of the function and expression of SLC38A5 and SLC7A11. Antioxidants (Basel) 13(3):291. 10.3390/antiox13030291
  8. Lange M. et al., (2025). FSP1-mediated lipid droplet quality control prevents neutral lipid peroxidation and ferroptosis. Nat. Cell Biol. 27(11):1902-1913. 10.1038/s41556-025-01790-y
  9. Miki K., Yagi M., Yoshimoto K., Kang D., & Uchiumi T. (2022). Mitochondrial dysfunction and impaired growth of glioblastoma cell lines caused by antimicrobial agents inducing ferroptosis under glucose starvation. Oncogenesis, 11(1), 59. 10.1038/s41389-022-00437-z
  10. Shiiba I., Ito N., Oshio H., et al. (2025). ER-mitochondria contacts mediate lipid radical transfer via RMDN3/PTPIP51 phosphorylation to reduce mitochondrial oxidative stress. Nature Communications, 16, 1508. 10.1038/s41467-025-56666-4
  11. Miki K., Yagi M., Kang D., Kunisaki Y., Yoshimoto K., & Uchiumi T. (2024). Glucose starvation causes ferroptosis-mediated lysosomal dysfunction. iScience, 27(5), 109735. 10.1016/j.isci.2024.109735
  12. Yagi M., Do Y., Hirai H., Miki K., Toshima T., Fukahori Y., Setoyama D., Abe C., Nabeshima Y. I., Kang D., & Uchiumi T. (2023). Improving lysosomal ferroptosis with NMN administration protects against heart failure. Life Science Alliance, 6(12), e202302116. 10.26508/lsa.202302116
  13. Do Y., Yagi M., Hirai H., Miki K., Fukahori Y., Setoyama D., Yamamoto M., Furukawa T., Kunisaki Y., Kang D., & Uchiumi T. (2024). Cardiomyocyte-specific deletion of the mitochondrial transporter Abcb10 causes cardiac dysfunction via lysosomal-mediated ferroptosis. Bioscience Reports, 44(5), BSR20231992. 10.1042/BSR20231992
  14. Loo T. M., Zhou X., Tanaka Y., Sugawara S., Yamauchi S., Kawasaki H., ... & Takahashi A. (2025). Senescence-associated lysosomal dysfunction impairs cystine deprivation-induced lipid peroxidation and ferroptosis. Nature Communications, 16, 6617. 10.1038/s41467-025-61894-9
  15. Unten Y., Takafuji K., Masukagami Y., Shiiba I., Horiuchi K., Husnik F., Yanagi S., Tateishi N., & Suzuki T. (2026). Characterizing mitochondrial phenotypes and MERCS in aged human skeletal muscle myoblasts. PLOS One, 21(2), e0343604. 10.1371/journal.pone.0343604
  16. Hirata Y., Yamada Y., Taguchi S., Kojima R., Masumoto H., Kimura S., ... & Matsuzawa A. (2024). Conjugated fatty acids drive ferroptosis through chaperone-mediated autophagic degradation of GPX4 by targeting mitochondria. Cell Death & Disease, 15(12), 884. 10.1038/s41419-024-07237-w
  17. Shinjyo N., Kimura H., Yoshihara T., Suzuki J., Yamaguchi M., Kawabata S., & Okabe Y. (2025). Aldehyde metabolism governs resilience of mucociliary clearance to air pollution exposure. The Journal of Clinical Investigation, 135(14), e191276. 10.1172/JCI191276
  18. Nguyen N. T., Sennoune S. R., Dharmalingam-Nandagopal G., Sivaprakasam S., Bhutia Y. D., & Ganapathy V. (2024). Impact of oncogenic changes in p53 and KRAS on macropinocytosis and ferroptosis in colon cancer cells and anticancer efficacy of niclosamide with differential effects on these two processes. Cells, 13(11), 951. 10.3390/cells13110951
Paper citation material — updated Oct 13, 2026.

Satisfaction
Quality Rating
Value Rating
Style Rating
X